On the first MPR pod of 2021 we cover the latest COVID-19 vaccine news including admin. scheduling and production; A diagnostics test that may be giving false negative results; Bristol Myers Squibb withdraws an indication for Opdivo; And experts vote on the best diets for 2021.
In the United States, the CDC has said that COVID-19 vaccines ‘are not interchangeable’.
Published data on Moderna vaccine show severe COVID-19 in 30 individuals — all in the placebo group — in trial of 30,420 participants.
The authors described the cases of 3 patients with moderate to severe COVID-19 pneumonia who were treated with 2g of icosapent ethyl administered twice daily via a nasogastric tube.
Additional research from the vaccine manufacturers would be needed to support any changes to the dosing schedule.
The test should be utilized in accordance with its Emergency Use Authorization and as described in the authorized labeling to reduce the risk of false negative results.
According to the Company, 18 million doses have thus far been supplied to the US government.
The vaccine candidate contains the Company’s saponin-based Matrix-M™ adjuvant technology to enhance and prolong immune responses.
Risk for mechanical ventilation use, admission to intensive care, longer length of stay increased for COVID-19 versus flu
Pfizer COVID-19 vaccine should not be administered to individuals with a known history of severe reaction to polyethylene glycol
